CYCLEV Trademark

Trademark Overview

On Wednesday, February 11, 2009, a trademark application was filed for CYCLEV with the United States Patent and Trademark Office. The USPTO has given the CYCLEV trademark a serial number of 77668020. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 8, 2012. This trademark is owned by Glaxo Group Limited. The CYCLEV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; vaccines
cyclev

General Information

Serial Number77668020
Word MarkCYCLEV
Filing DateWednesday, February 11, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 8, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 16, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; vaccines
Pseudo MarkCYCLE VACCINES

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 17, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Tuesday, October 9, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 8, 2012ABANDONMENT - NO USE STATEMENT FILED
Saturday, March 3, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 2, 2012EXTENSION 5 GRANTED
Tuesday, February 28, 2012EXTENSION 5 FILED
Tuesday, February 28, 2012TEAS EXTENSION RECEIVED
Tuesday, August 16, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 15, 2011EXTENSION 4 GRANTED
Thursday, August 4, 2011EXTENSION 4 FILED
Thursday, August 4, 2011TEAS EXTENSION RECEIVED
Wednesday, February 23, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 22, 2011EXTENSION 3 GRANTED
Friday, February 11, 2011EXTENSION 3 FILED
Friday, February 11, 2011TEAS EXTENSION RECEIVED
Thursday, September 9, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 8, 2010EXTENSION 2 GRANTED
Monday, August 16, 2010EXTENSION 2 FILED
Wednesday, September 8, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 16, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 16, 2010EXTENSION 1 GRANTED
Tuesday, February 16, 2010EXTENSION 1 FILED
Tuesday, February 16, 2010TEAS EXTENSION RECEIVED
Saturday, October 24, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 8, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 6, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 6, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 16, 2009PUBLISHED FOR OPPOSITION
Wednesday, May 27, 2009NOTICE OF PUBLICATION
Thursday, May 14, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, May 14, 2009ASSIGNED TO LIE
Thursday, May 14, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 14, 2009EXAMINER'S AMENDMENT ENTERED
Thursday, May 14, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, May 14, 2009EXAMINERS AMENDMENT E-MAILED
Thursday, May 14, 2009EXAMINERS AMENDMENT -WRITTEN
Friday, May 8, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 8, 2009NON-FINAL ACTION E-MAILED
Friday, May 8, 2009NON-FINAL ACTION WRITTEN
Friday, May 1, 2009ASSIGNED TO EXAMINER
Wednesday, February 18, 2009NOTICE OF PSEUDO MARK MAILED
Tuesday, February 17, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, February 14, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

cyclev pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic